Filing Details
- Accession Number:
- 0001140361-10-007442
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-02-18 12:00:00
- Reporting Period:
- 2010-02-16
- Filing Date:
- 2010-02-18
- Accepted Time:
- 2010-02-18 18:31:23
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1124105 | Targacept Inc | TRGT | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1178031 | Ralph Snyderman | C/O Targacept, Inc. 200 East First Street, Suite 300 Winston-Salem NC 27101 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2010-02-16 | 7,500 | $9.27 | 7,500 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2010-02-16 | 7,500 | $7.10 | 15,000 | No | 4 | M | Direct | |
Common Stock | Disposition | 2010-02-16 | 15,000 | $19.92 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2010-02-16 | 7,500 | $0.00 | 7,500 | $9.27 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2010-02-16 | 7,500 | $0.00 | 7,500 | $7.10 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
17,500 | 2017-06-19 | No | 4 | M | Direct | |
0 | 2009-06-09 | 2018-07-01 | No | 4 | M | Direct |
Footnotes
- This stock option vested (vests) and became (becomes) exercisable with respect to (a) one-third of the shares subject to the option on June 20, 2008 and (b) the remaining two-thirds of the shares subject to the option in pro rata quarterly installments over the second and third years following the date of grant so that the option will be vested and exercisable in full on the earlier of (i) June 20, 2010 or (ii) the business day immediately preceding the date of the issuer's annual meeting of stockholders that occurs in 2010, provided that the reporting person remains in service during such periods.